Progesterone receptor activity (PgR) and response to first endocrine therapy in advanced breast cancer: Significance of timing of receptor analysis
- Book ID
- 122654422
- Publisher
- Elsevier Science
- Year
- 1986
- Weight
- 178 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0277-5379
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This review presents our experience with the use of estrogen receptors (ER) and progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV breast cancer. Presence of ER (>3 fmoUmg cytosol protein) significantly predicted response to the antiestrogen tamoxifen and to
Histological sections obtained from 70 patients with breast cancer, all of whom had received endocrine therapy for metastatic or locally advanced disease, were assessed for specific immunocytochemical staining of oestrogen receptor and the oestrogen-induced protein pS2. There was also sufficient mat
Estrogen (ER) and progesterone (PgR) receptors were assayed by histochemistry in primary, recurrent, and metastatic breast cancer. Ligand-conjugates composed of 17P-estradiol and 1 lcu-hydroxyprogesterone covalently linked to bovine serum albumin and labelled with fluorescein isothiocyanate were emp